Itovebi is approved to treat patients with PIK3CA-mutated HR-positive, HER2 negative metastatic breast cancer in combination ...

The results come from a phase IIa safety and tolerability study. The drug’s developers say they are working with regulatory ...

The regimen has shown promise in preventing graft-versus-host disease in patients who received a haploidentical stem cell ...

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

The FDA approved Pfizer’s Hympavzi (marstacimab-hncq) to prevent or reduce the frequency of bleeding episodes in patients age ...

Itovebi is approved to treat patients with PIK3CA-mutated HR-positive, HER2 negative metastatic breast cancer in combination ...

Survey finds that people with chronic pain were more supportive of the policies that would expand access to medical cannabis.

The IQVIA analysis finds that the impact of drug price negotiation on patients’ out-of-pocket spending could also be smaller ...

The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health ...

Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...

Sanjula Jain of Trilliant Health talks about how employers are best positioned to demand value for money from the U.S.

One area of interest is whether ketogenic diets, which are high in fat and low in carbohydrates, might be helpful to people ...